1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNew York State Biodefense Commercialization Fund is sponsored by Empire State Development (New York State Urban Development Corporation d/b/a ESD). This fund accelerates the development and commercialization of life science research and innovations that address serious infectious health threats.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Biotech and Life Sciences | Empire State Development Biotech and Life Sciences Life Science is a Key Driver of Economic Growth New York’s diversity and strengths are enabling groundbreaking life science innovation Through strategic investment in biopharmaceutical, device and diagnostic research, development and manufacturing, New York fuels the creation of cutting-edge healthcare solutions.
New York is growing its life science industry through a broad range of economic development programs and public-private partnerships, supported by the state’s award-winning research talent. And through its $620 million Life Science Initiative, New York is expanding the state’s ability to commercialize research and spurring the growth of a world-class life science research cluster.
New York State’s Innovative Biotech and Life Sciences Industry Learn more about New York’s biotech and life sciences industry leadership from the top companies and research institutions that are creating jobs and innovating the future of healthcare.
New York is the Future of Life Science We’ve gathered highlights of the many New York State programs and investments that are creating one of the world’s most innovative life science ecosystems – in a convenient one-sheet reference guide that you can download and share.
New York’s statewide Cell and Gene Therapy (CGT) Initiative includes a $150 million investment in the development of the New York BioGenesis Park to be located on Long Island (pictured), which will transform CGT research, development and manufacturing statewide; and a $30 million investment to expand the CGT research and manufacturing facility at Roswell Park Comprehensive Cancer Center in Buffalo.
New York State is reshoring preclinical drug development with the “Lab of the Future. ” The lab will enable biopharma companies to leverage use of artificial intelligence (AI), machine learning (ML) and robotics to offer improved speed, precision and cost-efficiency to preclinical drug development with this next-generation pilot lab facility.
IndieBio New York is a startup development program backed by global venture fund, SOSV, which invests in early-stage life science startups that are tackling the world's most pressing problems in human and planetary health. IndieBio New York promotes innovation by offering companies a dedicated four-month educational program, investment, free lab space, and the opportunity to become part of New York's fast-growing life science ecosystem.
Biotech and Life Science in New York State Discover why New York State is the ideal place to launch or expand your business. in the nation for R&D spend by publicly traded life science companies in the state in the U.S. for NIH funding – approximately $3.
6B in the nation for highest number of bioscience patents issued New York State is Growing the Life Sciences Economy Life Sciences Tax Credit Program Supports new life sciences businesses locating, inventing, commercializing and producing in New York State. NYFIRST Medical School Grant Program NYFIRST provides grants of up to $1. 0 million to encourage recruitment or retention of exceptional translational researchers.
NYS Biodefense Commercialization Fund A $40 million grant fund for the development and commercialization of solutions for serious infectious disease threats. A one-stop-shop to New York's life science sector to access information and resources to support operations and growth.
Life Science Initiative: The Next Phase Life Science Initiative Annual Report: 2025 The Annual Report details the operations and accomplishments of New York State’s Life Science Initiative during 2025. Cell and Gene Therapy Innovation Hub New York BioGenesis Park, located on Long Island, will transform the research, development, and commercialization of life-saving therapies statewide.
Opportunities to grow your business in New York State All forms of tax incentives that enable savings and cost advantages to businesses. Programs offering assistance or training to ensure more competitive businesses. Funds, loans and other means of financial support to stimulate business growth.
Innovation Development Support Financial incentives to foster university collaboration, research and innovation. For press inquiries, please contact [email protected] Director, Industry Development; Life Sciences Biotech and Life Sciences
According to the current listing, eligibility includes: Incorporated companies (LLC, C-Corp, S-Corp, etc.) developing promising diagnostics, vaccines, therapeutics, and other innovations to prevent, treat or mitigate serious infectious disease threats. Confirm the full requirements in the official notice before applying.
The current listing shows up to $4,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
New York State Biodefense Commercialization Fund is funded by Empire State Development (New York State Urban Development Corporation d/b/a ESD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Governor Hochul's September 10 solicitation offers up to $25 million in capital grant funding for a Downstate semiconductor design center. Phase 1 concept papers are due October 26, 2026 at 2:00 p.m. The eligibility language excludes for-profit chip firms as prime applicants and the geography excludes everything north of Putnam County. Here is who can actually win this, and how the consortium should be built.
Read articleMissouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.
Read articleThe August 31 RFA for Round 2 of NY BRICKS makes $75 million available with a December 7 deadline — but the eligibility threshold jumped from 20 points to 31, the minimum award score went from 70 to 85, property acquisition became an ineligible use, and the renovation set-aside shrank 86 percent.
Read article